Involvement of the Nrf2 pathway in DR is supported by in vivo studies showing that, among others, a high glucose state in diabetes impairs Nrf2 activation and decreases Nrf2-target genes in the retina [43,52]. The gene discussed is NFE2L2; the disease is diabetes mellitus.